News
Explore Solid Biosciences’ potential with promising SGT-003 trial results for DMD, strong financials, and market recovery ...
A few weeks after Sarepta Therapeutics confirmed a patient died after receiving its drug Elevidys, research published April 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback